sterna biologicals Reports Phase 2a Study Data Demonstrating Efficacy of Its GATA3 Specific DNAzyme Formulation SB012 in Patients with Ulcerative Colitis

Data presented at the 13th Congress of ECCO European Crohn's and Colitis Organisation. SB012 was safe and well tolerated and led to marked clinical and endoscopic improvement in patients with active ulcerative colitis. This...